Status:
COMPLETED
Thromboelastography in Non-elective Cesarean Delivery
Lead Sponsor:
Stanford University
Conditions:
Bleeding
Eligibility:
FEMALE
18-40 years
Brief Summary
The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare co...
Detailed Description
The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). TEG is a point- of...
Eligibility Criteria
Inclusion
- Obstetric in-patients
- Laboring patients with Epidurals for Labor Analgesia going for non-elective Cesarean
- Patients of all ethnic backgrounds will be included
- Singleton pregnancy
- ASA 1 or 2
Exclusion
- Patients with underlying coagulation disorders.
- Patients with thrombocytopenia (platelet count \<100).
- Patients with pregnancy-induced hypertension, pre-eclampsia.
- Patients requiring the following medications prior to surgery: NSAIDS, aspirin, anticoagulants.
- Patients requiring elective Cesarean delivery.
- Patients with significant obstetric or medical disease.
- No patients \<18 years of age will be recruited.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01514591
Start Date
August 1 2011
End Date
June 1 2013
Last Update
June 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lucile Packard Children's Hospital
Stanford, California, United States, 94305